scholarly journals Translation, Cultural Adaptation and Validation of the Current Opioid Misuse Measure for European Portuguese

2020 ◽  
Vol 33 (4) ◽  
pp. 261
Author(s):  
Diogo Mendes-Morais ◽  
Cláudia Jantarada ◽  
Luís Guimarães-Pereira

Introduction: Current practice guidelines recommend using Current Opioid Misuse Measure to screen aberrant opioid-related behaviors in chronic pain patients. Our aims were to translate, adapt and validate it to be used in Portuguese chronic pain patients.Material and Methods: Translation and cultural adaptation process followed guidelines and a model of principles for good practice. Adult chronic pain patients on opioid therapy, from one major hospital in Portugal, were invited to complete the translated version. Descriptive statistics, Cronbach’s alpha, inter-item, item-total and intra-class correlation coefficients and principal components analysis were applied.Results: Translation process was performed as planned and the validation sample was composed by 98 patients (median age = 62.5 years). Regarding internal consistency, a global Cronbach’s alpha of 0.778 was obtained and item-total correlations of all items were above 0.20 with four exceptions. An intra-class correlation coefficient of 0.90 was found between test and retest. Regarding validity, all 17 items presented a content validity index above 0.80. Six principal components were extracted and explained 66.3% of the variance.Discussion: The Portuguese version of Current Opioid Misuse Measure was properly translated, adapted and validated; showing good quality in terms of reliability and validity. This is the first instrument to screen aberrant opioid-related behaviors in Portuguese chronic pain patients. Consequently, it will aid and promote the identification of opioid misuse in these patients.Conclusion: The implementation of this questionnaire may reduce the incidence and morbimortality of opioid misuse among chronic pain patients and should improve chronic pain treatment in Portugal.

2008 ◽  
Vol 24 (6) ◽  
pp. 497-508 ◽  
Author(s):  
Dennis C. Turk ◽  
Kimberly S. Swanson ◽  
Robert J. Gatchel

2010 ◽  
Vol 26 (9) ◽  
pp. 770-776 ◽  
Author(s):  
Stephen F. Butler ◽  
Simon H. Budman ◽  
Gilbert J. Fanciullo ◽  
Robert N. Jamison

2015 ◽  
Vol 16 (4) ◽  
pp. S84
Author(s):  
D. Jurcik ◽  
E. Ross ◽  
E. Scanlan ◽  
R. Jamison ◽  
M. Matthews

2021 ◽  
Vol 11 (1) ◽  
pp. 151
Author(s):  
María del Rocío Ibancos-Losada ◽  
María Catalina Osuna-Pérez ◽  
Irene Cortés-Pérez ◽  
Desirée Montoro-Cárdenas ◽  
Ángeles Díaz-Fernández

Experimental pain testing requires specific equipment and may be uncomfortable for patients. The Pain Sensitivity Questionnaire (PSQ) was developed to assess pain sensitivity, based on the pain intensity ratings (range: 0–10) of painful situations that occur in daily life. The main objective of this study was to carry out a cross-cultural adaptation and validation of the Spanish version of the PSQ (PSQ-S). A total of 354 subjects (296 healthy and 58 chronic pain patients) filled in the PSQ-S. A subgroup of 116 subjects performed experimental pain testing, including two modalities (cold and pressure), with different measures: pain intensity rating, pressure pain threshold, and tolerance. The validation results showed two factors: PSQ-S-moderate and PSQ-S-minor and, for the total scale and the two factors, an excellent internal consistency (Cronbach’s alpha coefficient > 0.9) and a substantial reliability (Intraclass Correlation Coefficient > 0.8). We obtained strong correlations with all the experimental pain rating parameters, catastrophizing, and depression variables, as well as moderate correlations with anxiety, central sensibilization, and impact on the quality of life. Chronic pain patients received elevated PSQ-S scores compared to healthy controls, and three cut-off values (PSQ-S-total = 7.00, PSQ-S-moderate = 7.57, and PSQ-S-minor = 6.29) based on ROC curve analyses were shown to be able to discriminate between healthy adults and adults with chronic pain. Therefore, PSQ-S may be a simple alternative to experimental pain procedures for clinical and experimental pain research.


2009 ◽  
Vol 3 (2) ◽  
pp. 66-73 ◽  
Author(s):  
Stephen F. Butler ◽  
Simon H. Budman ◽  
Kathrine C. Fernandez ◽  
Gilbert J. Fanciullo ◽  
Robert N. Jamison

Author(s):  
M. A. Cherkasov ◽  
A. S. Ibiev ◽  
A. V. Saraev ◽  
N. N. Kornilov

Purpose . To perform language and cultural adaptation of the Hospital of Special Surgery (HSS) Knee Replacement Expectations Survey and evaluate its reliability.Material and methods . To preserve the HSS validity its language and cultural adaptation was performed in several steps: (1) direct translation, (2) synthesis of the intermediate version, (3) back translation, (4) expert commission review and creation of the 2nd intermediate version, (5) pre-testing and formation of a final version, study of reliability with evaluation of Cronbach’s alpha and intra class correlation coefficient (ICC). Total number of 35 patients (mean age 54.2 years) with terminal-stage gonarthrosis who were admitted for total knee arthroplasty (TKA) participated in the study.Results . Cronbach’s alpha and intra class correlation coefficient (ICC) for the translated and adapted version of HSS Knee Replacement Expectations Survey made up 0.871 and 0.82 (95% confidence interval 0.725-0.897) that was indicative of high correlation between Russian version and the original.Conclusion . Russian version of HSS Knee Replacement Expectations Survey is a reliable tool and can be used for the evaluation of patient expectations prior to TKA.


2019 ◽  
Vol 50 (4) ◽  
pp. 644-652 ◽  
Author(s):  
Scott J. Moeller ◽  
Adam W. Hanley ◽  
Eric L. Garland

AbstractBackgroundThe USA is currently enduring an opioid crisis. Identifying cost-effective, easy-to-implement behavioral measures that predict treatment outcomes in opioid misusers is a crucial scientific, therapeutic, and epidemiological goal.MethodsThe current study used a mixed cross-sectional and longitudinal design to test whether a behavioral choice task, previously validated in stimulant users, was associated with increased opioid misuse severity at baseline, and whether it predicted change in opioid misuse severity at follow-up. At baseline, data from 100 prescription opioid-treated chronic pain patients were analyzed; at follow-up, data were analyzed in 34 of these participants who were non-misusers at baseline. During the choice task, participants chose under probabilistic contingencies whether to view opioid-related images in comparison with affectively pleasant, unpleasant, and neutral images. Following previous procedures, we also assessed insight into choice behavior, operationalized as whether (yes/no) participants correctly self-reported the image category they chose most often.ResultsAt baseline, the higher choice for viewing opioid images in direct comparison with pleasant images was associated with opioid misuse and impaired insight into choice behavior; the combination of these produced especially elevated opioid-related choice behavior. In longitudinal analyses of individuals who were initially non-misusers, higher baseline opioid v. pleasant choice behavior predicted more opioid misuse behaviors at follow-up.ConclusionsThese results indicate that greater relative allocation of behavior toward opioid stimuli and away from stimuli depicting natural reinforcement is associated with concurrent opioid misuse and portends vulnerability toward future misuse. The choice task may provide important medical information to guide opioid-prescribing practices.


2019 ◽  
Vol 50 (12) ◽  
pp. 1977-1988 ◽  
Author(s):  
Eric L. Garland ◽  
Martin Trøstheim ◽  
Marie Eikemo ◽  
Gernot Ernst ◽  
Siri Leknes

AbstractBackgroundBoth acute and chronic pain can disrupt reward processing. Moreover, prolonged prescription opioid use and depressed mood are common in chronic pain samples. Despite the prevalence of these risk factors for anhedonia, little is known about anhedonia in chronic pain populations.MethodsWe conducted a large-scale, systematic study of anhedonia in chronic pain, focusing on its relationship with opioid use/misuse, pain severity, and depression. Chronic pain patients across four distinct samples (N = 488) completed the Snaith–Hamilton Pleasure Scale (SHAPS), measures of opioid use, pain severity and depression, as well as the Current Opioid Misuse Measure (COMM). We used a meta-analytic approach to determine reference levels of anhedonia in healthy samples spanning a variety of countries and diverse age groups, extracting SHAPS scores from 58 published studies totaling 2664 psychiatrically healthy participants.ResultsCompared to healthy samples, chronic pain patients showed higher levels of anhedonia, with ~25% of patients scoring above the standard anhedonia cut-off. This difference was not primarily driven by depression levels, which explained less than 25% of variance in anhedonia scores. Neither opioid use duration, dose, nor pain severity alone was significantly associated with anhedonia. Yet, there was a clear effect of opioid misuse, with opioid misusers (COMM ⩾13) reporting greater anhedonia than non-misusers. Opioid misuse remained a significant predictor of anhedonia even after controlling for pain severity, depression and opioid dose.ConclusionsStudy results suggest that both chronic pain and opioid misuse contribute to anhedonia, which may, in turn, drive further pain and misuse.


Sign in / Sign up

Export Citation Format

Share Document